secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kaival Brands Innovations Group, Inc. (KAVL)
CIK:        0001762239
Form:       8-K
Filed at:   2024-09-20T23:59:59+00:00
Accession:  0001731122-24-001463
Event type: regulatory
Sentiment:  negative
Materiality: 0.55
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Kaival Brands receives Nasdaq deficiency notice for bid price below $1.00; 180-day cure period until March 17, 2025
--------------------------------------------------------------------------------

- Notification on Sept 16, 2024 of non-compliance with Nasdaq minimum bid price of $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until March 17, 2025, to regain compliance by closing at $1.00+ for 10 consecutive trading days.
- If not cured, may qualify for an additional 180-day period by meeting other listing standards and intending a reverse stock split.
- Common stock continues trading on Nasdaq Capital Market; failure to cure could result in delisting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1762239/000173112224001463/0001731122-24-001463-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1762239/000173112224001463/e5955_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-24-001463

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer